Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Immunic, Inc. (IMUX) had Non-Operating Income/Expense of $1.35M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-25.47M |
|
-- |
|
-- |
|
$26.82M |
|
$-26.82M |
|
|
Non-Operating Income/Expense |
$1.35M |
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-26.82M |
|
$-26.78M |
|
101.34M |
|
101.34M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$18.98M |
|
$0.57M |
|
$1.54M |
|
$20.52M |
|
$25.59M |
|
-- |
|
$0.21M |
|
$25.80M |
|
$-5.29M |
|
$-5.29M |
|
$-5.29M |
|
90.15M |
|
| Cash Flow Statement Financials | |
$-21.78M |
|
$-0.05M |
|
$0.00M |
|
$35.67M |
|
$14.30M |
|
$-21.36M |
|
$2.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
481.80% |
|
481.80% |
|
-124.17% |
|
481.80% |
|
$-0.06 |
|
$-0.22 |
|
$-0.21 |
|